Creative Biogene, the world’s leading biotechnology products, and services provider focuses on offering professional support for virus-related researches and accelerates the development in the pharmaceutical and biotechnology industry, recently announces the release of its retrovirus service in order to improve retrovirus expression studies. —
With years of experience, Creative Biogene is in a leading position in the development of retroviral technology, aiming to provide researchers from all over the world with valuable research tools. Creative Biogene’s team utilizes improved technology to increase the success rate of retroviral expression research, including highly efficient retroviral packaging cell lines, rapid retroviral vector construction, and methods that can significantly increase the transduction rate of retroviral vectors to multiple cell types.
Creative Biogene’s customized retrovirus production services include: 1) construction of retroviral plasmid vectors; 2) retroviral packaging; 3) retroviral purification; 4) retroviral titration. For more than ten years, Creative Biogene's retrovirus production team has built, packaged, and purified hundreds of retroviruses ranging from small-scale to large-scale purification for global customers. For more than ten years, Creative Biogene's retrovirus production team has built, packaged, and purified hundreds of retroviruses ranging from small-scale to large-scale purification for global customers. In addition, Creative Biogene has been optimizing the retrovirus production system, including retroviral plasmid construction and low endotoxin plasmid preparation, host cells used for retrovirus packaging, cell culture media, and retrovirus packaging process, small and large retrovirus purification process.
Recombinant Moloney Murine Leukemia Virus (MMLV) retroviral vector can be used as an effective viral vector tool to permanently introduce genes into a variety of dividing cells. This retroviral system has attracted much attention as a gene delivery method for generating iPS cells. Creative Biogene has developed a series of proprietary technologies and reagents in terms of titer, purity, viability and consistency, especially the MMLV vector system used in vector cloning services. Retroviral vectors can provide high-level expression of various inserted genes, such as cytokines, receptors, enzymes and growth factors, greatly improved the recombinant MMLV retrovirus production program. For each recombinant MMLV retrovirus produced by Creative Biogene, quality control includes titer measurement, sterility testing for bacteria and fungi, and mycoplasma testing.
“The custom retrovirus provided by Creative Biogene is an efficient method that can achieve stable gene expression in a wide range of dividing mammalian cells. Simply provide genetic data, or purchase ORF vectors from Creative Biogene’s extensive human, mouse or rat gene system, and we will provide packaged retroviral results based on your requirements,” said Marcia Brady, the marketing director of Creative Biogene.
About Creative Biogene
Creative Biogene, as a top-of-its-kind company that holds a leading position and is committed to accelerating the development of human science through biotechnology, offering innovative technologies, products, unique tools and services for research discoveries and product development. With more than 10 years of experience and in-house experts, Creative Biogene has become a well-recognized industry leader to support researchers worldwide.
Release ID: 88980883